Nath Bio-Genes (India) Ltd - 537291 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information Regarding Issue of Duplicate share Certificate.01-11-2019
01-11-2019
Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.30-10-2019
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Conference Call Intimation.25-10-2019
Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate For The Half Year Ended 30Th September 2019.
Compliance Certificate for the half year ended 30th September 2019.24-10-2019
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2019
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2019 ,inter alia, to consider and approve Board Meeting Intimation for approval of unaudited financial results for the quarter and half year ended 30th September 201924-10-2019
Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate Under SEBI (LODR) Reg 40(10) For The Half Year Ended 30Th September 2019.
Compliance Certificate under SEBI (LODR) Reg 40(10) for the half year ended 30th September 2019.21-10-2019
Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window
Closure of Trading Window.16-10-2019
Nath Bio-Genes (India) Ltd - 537291 - Shareholding for the Period Ended September 30, 2019
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here15-10-2019
Nath Bio-Genes (India) Ltd - 537291 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- DHIRAJ RATHIDesignation :- Company Secretary and Compliance Officer12-10-2019
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Meet and Site Visit on 05th Oct 2019.05-10-2019